Journal of General Internal Medicine

, Volume 26, Issue 3, pp 251–258 | Cite as

Presence and Correlates of Racial Disparities in Adherence to Colorectal Cancer Screening Guidelines

  • Diana J. Burgess
  • Michelle van Ryn
  • Joseph Grill
  • Siamak Noorbaloochi
  • Joan M. Griffin
  • Jennifer Ricards
  • Sally W. Vernon
  • Deborah A. Fisher
  • Melissa R. Partin
Original Research



We examined the presence and correlates of Black/White racial disparities in adherence to guidelines for colorectal cancer screening (CRCS).


The sample included 328 Black and 1827 White patients age 50–75 from 24 VA medical facilities who responded to a mailed survey with phone follow-up (response rate: 73% for Blacks and 89% for Whites). CRCS adherence and race were obtained through surveys and supplemented with administrative data. Logistic regressions estimated the contribution of demographic, health, cognitive, and environmental factors to racial disparities in adherence to CRCS guidelines.


In unadjusted analyses, Blacks had slightly lower rates of adherence to CRCS guidelines than Whites (72% versus 77%, p < 0.05). This racial disparity in CRCS adherence was explained by race differences in demographic, health, and environmental factors but not by cognitive factors. Tests for interactions revealed that the association of race with adherence varied significantly across levels of income, education, and marital status. In particular, among those who were married with higher levels of education, CRCS adherence was significantly higher for Whites; whereas among those who were unmarried, with low levels of education, adherence was significantly higher for Blacks.


We found that disparities in CRCS are greatly attenuated in the VA system and both Whites and Blacks have substantially higher rates of CRCS than the national average. These results point to the success of the VA at implementing CRCS system-wide. Our findings also suggest additional initiatives may be needed for unmarried low income white men and higher income black men.


colorectal cancer cancer screening disparities minority health Veterans 


  1. 1.
    Cancer Facts and Figures 2007. Atlanta: American Cancer Society; 2007.Google Scholar
  2. 2.
    Chien C, Morimoto LM, Tom J, Li CI. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005;104(3):629–39.CrossRefPubMedGoogle Scholar
  3. 3.
    Polite BN, Dignam JJ, Olopade OI. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006;24(14):2179–87.CrossRefPubMedGoogle Scholar
  4. 4.
    Polite BN, Dignam JJ, Olopade OI. Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites. Med Clin North Am. 2005;89(4):771–93.CrossRefPubMedGoogle Scholar
  5. 5.
    Berry J, Bumpers K, Ogunlade V, et al. Examining racial disparities in colorectal cancer care. J Psychosoc Oncol. 2009;27(1):59–83.CrossRefPubMedGoogle Scholar
  6. 6.
    Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003;124(2):544–60.CrossRefPubMedGoogle Scholar
  7. 7.
    Agrawal S, Bhupinderjit A, Bhutani MS, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100(3):515–23. discussion 514.CrossRefPubMedGoogle Scholar
  8. 8.
    Palmer RC, Schneider EC. Social disparities across the continuum of colorectal cancer: a systematic review. Cancer Causes Control. 2005;16(1):55–61.CrossRefPubMedGoogle Scholar
  9. 9.
    Gornick ME, Eggers PW, Riley GF. Associations of race, education, and patterns of preventive service use with stage of cancer at time of diagnosis. Health Serv Res. 2004;39(5):1403–27.CrossRefPubMedGoogle Scholar
  10. 10.
    Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004;38(5):536–50.CrossRefPubMedGoogle Scholar
  11. 11.
    McQueen A, Vernon SW, Myers RE, Watts BG, Lee ES, Tilley BC. Correlates and predictors of colorectal cancer screening among male automotive workers. Cancer Epidemiol Biomark Prev. 2007;16(3):500–9.CrossRefGoogle Scholar
  12. 12.
    Beydoun HA, Beydoun MA. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 2008;19(4):339–59.CrossRefPubMedGoogle Scholar
  13. 13.
    Fisher DA, Dougherty K, Martin C, Galanko J, Provenzale D, Sandler RS. Race and colorectal cancer screening: a population-based study in North Carolina. N C Med J. 2004;65(1):12–5.PubMedGoogle Scholar
  14. 14.
    Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100(10):2093–103.CrossRefPubMedGoogle Scholar
  15. 15.
    James TM, Greiner KA, Ellerbeck EF, Feng C, Ahluwalia JS. Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethn Dis. 2006;16(1):228–33.PubMedGoogle Scholar
  16. 16.
    Jerant AF, Fenton JJ, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med. 2008;168(12):1317–24.CrossRefPubMedGoogle Scholar
  17. 17.
    Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41(1):23–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 national health interview survey. Cancer Epidemiol Biomark Prev. 2008;17(7):1623–30.CrossRefGoogle Scholar
  19. 19.
    O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165(18):2129–35.CrossRefPubMedGoogle Scholar
  20. 20.
    Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007;167(3):258–64.CrossRefPubMedGoogle Scholar
  21. 21.
    Chao HH, Schwartz AR, Hersh J, et al. Improving colorectal cancer screening and care in the veterans affairs healthcare system. Clin Colorectal Cancer. 2009;8(1):22–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Evans DC, Nichol WP, Perlin JB. Effect of the implementation of an enterprise-wide electronic health record on productivity in the Veterans Health Administration. Health Econ Policy Law. 2006;1(Pt 2):163–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Kizer KW. The "new VA": a national laboratory for health care quality management. Am J Med Qual. 1999;14(1):3–20.CrossRefPubMedGoogle Scholar
  24. 24.
    Jha AK, Perlin JB, Kizer KW, Dudley RA. Effect of the transformation of the veterans affairs health care system on the quality of care. N Engl J Med. 2003;348(22):2218–27.CrossRefPubMedGoogle Scholar
  25. 25.
    Performance OoQa. Measure master report for national quarter 2 FY2009: Veteran's Health Administration; 2009.Google Scholar
  26. 26.
    NIH State-of-the-Science Conference. Enhancing use and quality of colorectal cancer screening February 2–4 2010: final panel statement. Maryland: Bethesda; 2010.Google Scholar
  27. 27.
    Sequist TD, Adams A, Zhang F, Ross-Degnan D, Ayanian JZ. Effect of quality improvement on racial disparities in diabetes care. Arch Intern Med. 2006;166(6):675–81.CrossRefPubMedGoogle Scholar
  28. 28.
    Sehgal AR. Impact of quality improvement efforts on race and sex disparities in hemodialysis. Jama. 2003;289(8):996–1000.CrossRefPubMedGoogle Scholar
  29. 29.
    Saha S, Freeman M, Toure J, Tippens KM, Weeks C, Ibrahim S. Racial and Ethnic Disparities in the VA Health Care System: A Systematic Review. Journal of General Internal Medicine. 2008.Google Scholar
  30. 30.
    Etzioni DA, Yano EM, Rubenstein LV, et al. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum. 2006;49(7):1002–10.CrossRefPubMedGoogle Scholar
  31. 31.
    Dolan NC, Ferreira MR, Fitzgibbon ML, et al. Colorectal cancer screening among African-American and white male veterans. Am J Prev Med. 2005;28(5):479–82.CrossRefPubMedGoogle Scholar
  32. 32.
    Ajzen I. The Theory of Planned Behavior. Organ Behav Hum Decis Process. 1991;50:179–211.CrossRefGoogle Scholar
  33. 33.
    Bandura A. Health promotion from the perspective of social cognitive theory. Psychol Health. 1998;13:623–49.CrossRefGoogle Scholar
  34. 34.
    Rosenstock I, Kirscht J. The health belief model and personal health behavior.Google Scholar
  35. 35.
    Weinrich SP, Weinrich MC, Boyd MD, Johnson E, Frank-Stromborg M. Knowledge of colorectal cancer among older persons. Cancer Nurs. 1992;15(5):322–30.CrossRefPubMedGoogle Scholar
  36. 36.
    Jepson C, Kessler LG, Portnoy B, Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health. 1991;81(4):501–4.CrossRefPubMedGoogle Scholar
  37. 37.
    Wolf RL, Zybert P, Brouse CH, et al. Knowledge, beliefs, and barriers relevant to colorectal cancer screening in an urban population: a pilot study. Fam Community Health. 2001;24(3):34–47.PubMedGoogle Scholar
  38. 38.
    Greiner KA, James AS, Born W, et al. Predictors of fecal occult blood test (FOBT) completion among low-income adults. Prev Med. 2005;41(2):676–84.CrossRefPubMedGoogle Scholar
  39. 39.
    Zimmerman RK, Tabbarah M, Trauth J, Nowalk MP, Ricci EM. Predictors of lower endoscopy use among patients at three inner-city neighborhood health centers. J Urban Health. 2006;83(2):221–30.CrossRefPubMedGoogle Scholar
  40. 40.
    Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med. 2003;37(6 Pt 1):627–34.CrossRefPubMedGoogle Scholar
  41. 41.
    McAlearney AS, Reeves KW, Dickinson SL, et al. Racial differences in colorectal cancer screening practices and knowledge within a low-income population. Cancer. 2008;112(2):391–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Ogedegbe G, Cassells AN, Robinson CM, et al. Perceptions of barriers and facilitators of cancer early detection among low-income minority women in community health centers. J Natl Med Assoc. 2005;97(2):162–70.PubMedGoogle Scholar
  43. 43.
    Finney Rutten LJ, Nelson DE, Meissner HI. Examination of population-wide trends in barriers to cancer screening from a diffusion of innovation perspective (1987-2000). Prev Med. 2004;38(3):258–68.CrossRefPubMedGoogle Scholar
  44. 44.
    Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Prev Med. 2000;31(4):410–6.CrossRefPubMedGoogle Scholar
  45. 45.
    Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Washington: National Academy Press; 2002. Medicine; Io, ed.Google Scholar
  46. 46.
    Morrow GR, Way J, Hoagland AC, Cooper R. Patient compliance with self-directed Hemoccult testing. Prev Med. 1982;11(5):512–20.CrossRefPubMedGoogle Scholar
  47. 47.
    Richardson JL, Danley K, Mondrus GT, Deapen D, Mack T. Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative. Prev Med. 1995;24(2):166–70.CrossRefPubMedGoogle Scholar
  48. 48.
    Thomas W, White CM, Mah J, Geisser MS, Church TR, Mandel JS. Longitudinal compliance with annual screening for fecal occult blood. Minnesota Colon Cancer Control Study. Am J Epidemiol. 1995;142(2):176–82.PubMedGoogle Scholar
  49. 49.
    El-Serag HB, Petersen L, Hampel H, Richardson P, Cooper G. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med. 2006;166(20):2202–08.CrossRefPubMedGoogle Scholar
  50. 50.
    Vernon SW, Meissner H, Klabunde C, et al. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomark Prev. 2004;13(6):898–905.Google Scholar
  51. 51.
    Partin MR, Grill J, Noorbaloochi S, et al. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomark Prev. 2008;17(4):768–76.CrossRefGoogle Scholar
  52. 52.
    Partin MR, Noorbaloochi S, Grill J, et al. The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening adherence. Cancer Causes Control.Google Scholar
  53. 53.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMedGoogle Scholar
  54. 54.
    Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.CrossRefPubMedGoogle Scholar
  55. 55.
    Nelson DE, Kreps GL, Hesse BW, et al. The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun. 2004;9(5):443–60. discussion 481-444.CrossRefPubMedGoogle Scholar
  56. 56.
    Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomark Prev. 1997;6(10):825–32.Google Scholar
  57. 57.
    Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med (1982). 1991;32(6):705–14.CrossRefGoogle Scholar
  58. 58.
    Tiro JA, Vernon SW, Hyslop T, Myers RE. Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians. Cancer Epidemiol Biomark Prev. 2005;14(12):2855–61.CrossRefGoogle Scholar
  59. 59.
    Yano EM, Soban LM, Parkerton PH, Etzioni DA. Primary care practice organization influences colorectal cancer screening performance. Health Serv Res. 2007;42(3 Pt 1):1130–49.CrossRefPubMedGoogle Scholar
  60. 60.
    Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17(14):1623–34.CrossRefPubMedGoogle Scholar
  61. 61.
    Little RJ, Rubin DB. Statistical analysis with missing data; 2002.Google Scholar
  62. 62.
    Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons, Inc.; 1987.CrossRefGoogle Scholar
  63. 63.
    Little RJA. Survey nonresponse adjustments for estimates of means. Int Stat Rev. 1986;54:139–57.CrossRefGoogle Scholar
  64. 64.
    Smith PJ, Rao JNK, Battaglia MP, Ezzati-Rice TM, Daniels D, Khare M. Compensating for provider nonresponse using response propensity to form adjustment cells: the national immunization survey. Vital and Health Statistics. 2001;2:133.Google Scholar
  65. 65.
    Schenck AP, Klabunde CN, Davis WW. Racial differences in colorectal cancer test use by Medicare consumers. Am J Prev Med. 2006;30(4):320–6.CrossRefPubMedGoogle Scholar
  66. 66.
    Shokar NK, Carlson CA, Weller SC. Factors associated with racial/ethnic differences in colorectal cancer screening. J Am Board Fam Med. 2008;21(5):414–26.CrossRefPubMedGoogle Scholar
  67. 67.
    Rao RS, Graubard BI, Breen N, Gastwirth JL. Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: results from the 1998 National Health Interview Survey. Med Care. 2004;42(8):789–800.CrossRefPubMedGoogle Scholar
  68. 68.
    Use of colorectal cancer tests-United States, 2002, 2004, and 2006. Morbidity and Mortality Weekly Report. 2008;57(10):253–8.Google Scholar
  69. 69.
    Quality AfHRa. 2007 National Healthcare Disparities Report. Rockville: U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality; 2008.Google Scholar
  70. 70.
    Weeks WB, Kazis LE, Shen Y, et al. Differences in health-related quality of life in rural and urban veterans. Am J Public Health. 2004;94(10):1762–7.CrossRefPubMedGoogle Scholar
  71. 71.
    Weeks WB, Wallace AE, West AN, Heady HR, Hawthorne K. Research on rural veterans: an analysis of the literature. J Rural Health. 2008;24(4):337–44.CrossRefPubMedGoogle Scholar
  72. 72.
    Fihn SD. Improving quality: lessons from the Department of Veterans Affairs. Circulation. 2009;2(4):294–6.PubMedGoogle Scholar
  73. 73.
    Fisher DA, Jeffreys A, Coffman CJ, Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomark Prev. 2006;15(6):1232–5.CrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2010

Authors and Affiliations

  • Diana J. Burgess
    • 1
    • 2
  • Michelle van Ryn
    • 3
  • Joseph Grill
    • 1
  • Siamak Noorbaloochi
    • 1
    • 2
  • Joan M. Griffin
    • 1
    • 2
  • Jennifer Ricards
    • 4
  • Sally W. Vernon
    • 5
  • Deborah A. Fisher
    • 6
  • Melissa R. Partin
    • 1
    • 2
  1. 1.Center for Chronic Disease Outcomes ResearchMinneapolis VA Medical CenterMinneapolisUSA
  2. 2.Department of MedicineUniversity of MinnesotaMinneapolisUSA
  3. 3.Department of Family Medicine and Community Health and Division of EpidemiologyUniversity of MinnesotaMinneapolisUSA
  4. 4.Thomson ReutersHealthcare and ScienceSanta BarbaraUSA
  5. 5.Division of Health Promotion and Behavioral SciencesUniversity of Texas-Houston School of Public HealthHoustonUSA
  6. 6.Durham Veterans Affairs Medical Center and Duke University Medical CenterDurhamUSA

Personalised recommendations